Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives

Abstract Multiple sclerosis (MS) is a chronic, progressive, inflammatory disorder of the central nervous system. Relapsing–remitting MS (RRMS), the most common form of the disease, is characterized by transient neurological dysfunction with concurrent accumulation of disability. Over the past three...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Neurology and Therapy
المؤلفون الرئيسيون: Mark S. Freedman, Patricia K. Coyle, Kerstin Hellwig, Barry Singer, Daniel Wynn, Bianca Weinstock-Guttman, Silva Markovic-Plese, Andrew Galazka, Fernando Dangond, Julie Korich, Anthony T. Reder
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Adis, Springer Healthcare 2024-01-01
الموضوعات:
Disease-modifying therapies
Interferons
Interferon-beta-1a
Interferon-β-1a for subcutaneous injection
Multiple sclerosis
Relapsing–remitting multiple sclerosis
الوصول للمادة أونلاين:https://doi.org/10.1007/s40120-023-00565-7

الانترنت

https://doi.org/10.1007/s40120-023-00565-7

مواد مشابهة